New Delhi: India is unlikely to buy pfizer And Modern Sources said domestic manufacturing of COVID-19 vaccines has picked up pace for now with anti-coronavirus jabs, taking the overall Quantity Method Administered in the country across 83 crores on Wednesday.
While there is no official word, sources said the government is unwilling to give in to US drugmakers’ indemnity demands against liabilities in case of adverse effects.
Pune-based pharmaceutical company Serum Institute of India has increased Covishield’s manufacturing capacity to over 200 million per month and informed the Center that it will be able to supply around 22 crore doses in October.
In addition, Bharat Biotech is currently producing around 30 million doses of Covaxin every month and its production is expected to increase to 50 million in the coming months.
“In the early days Vaccination Drives, jabs were required, but domestic production has boomed. Also, these indigenously produced vaccines are much more economical and do not require special cold chains,” a source told PTI.
Union Health Minister Mansukh Mandaviya on Monday announced that India will resume export of surplus COVID-19 In the fourth quarter of 2021 under the ‘Vaccine Friendship’ program and fulfilling its commitment to the COVAX Global Pool, vaccinating its citizens remains the government’s top priority.
Talking about the expected production and supply trends in the coming months, he said that the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the coming quarter from October-December. . .
The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination campaign have exceeded 83 crore.
According to official sources, over 22 per cent of India’s adult population has received both doses of the vaccine and 65 per cent have received at least one dose.
Of all vaccines administered, about 88.45 percent are Covishield, about 11.44 percent Covaxin, and less than one percent are Sputnik V.
India administered a record number of over 2.50 crore vaccine doses on the occasion of Prime Minister Narendra Modi’s 71st birthday on September 17.
The daily COVID-19 vaccination in the country was over 1 crore on 6 September, 31 August and 27 August.
According to the ministry, it took 85 days for India to touch the 100 million immunization mark, 45 days to cross the 200 million mark and 29 days to reach the 300 million mark.
It said it took 24 days for the country to go from 30 crore doses to 40 crore and then 20 days to cross the 50 crore vaccination mark on 6 August.
It took 19 more days to cross 60 crores mark and only 13 days to reach 70 crores from 60 crores on 7th September.
Then it took just 11 days to reach from 70 crores to 80 crores.
While there is no official word, sources said the government is unwilling to give in to US drugmakers’ indemnity demands against liabilities in case of adverse effects.
Pune-based pharmaceutical company Serum Institute of India has increased Covishield’s manufacturing capacity to over 200 million per month and informed the Center that it will be able to supply around 22 crore doses in October.
In addition, Bharat Biotech is currently producing around 30 million doses of Covaxin every month and its production is expected to increase to 50 million in the coming months.
“In the early days Vaccination Drives, jabs were required, but domestic production has boomed. Also, these indigenously produced vaccines are much more economical and do not require special cold chains,” a source told PTI.
Union Health Minister Mansukh Mandaviya on Monday announced that India will resume export of surplus COVID-19 In the fourth quarter of 2021 under the ‘Vaccine Friendship’ program and fulfilling its commitment to the COVAX Global Pool, vaccinating its citizens remains the government’s top priority.
Talking about the expected production and supply trends in the coming months, he said that the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the coming quarter from October-December. . .
The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination campaign have exceeded 83 crore.
According to official sources, over 22 per cent of India’s adult population has received both doses of the vaccine and 65 per cent have received at least one dose.
Of all vaccines administered, about 88.45 percent are Covishield, about 11.44 percent Covaxin, and less than one percent are Sputnik V.
India administered a record number of over 2.50 crore vaccine doses on the occasion of Prime Minister Narendra Modi’s 71st birthday on September 17.
The daily COVID-19 vaccination in the country was over 1 crore on 6 September, 31 August and 27 August.
According to the ministry, it took 85 days for India to touch the 100 million immunization mark, 45 days to cross the 200 million mark and 29 days to reach the 300 million mark.
It said it took 24 days for the country to go from 30 crore doses to 40 crore and then 20 days to cross the 50 crore vaccination mark on 6 August.
It took 19 more days to cross 60 crores mark and only 13 days to reach 70 crores from 60 crores on 7th September.
Then it took just 11 days to reach from 70 crores to 80 crores.
.